1350308-04-1Relevant articles and documents
Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors
Murugesan, Vanangamudi,Tiwari, Vinay S.,Saxena, Reshu,Tripathi, Rajkamal,Paranjape, Ramesh,Kulkarni, Smita,Makwana, Nandini,Suryawanshi, Rahul,Katti, Seturam B.
experimental part, p. 6919 - 6926 (2011/12/16)
Based on rational drug design approach, a series of novel thiazolidin-4-ones bearing different aryl/heteroaryl moieties at position C-2 and N-3 are synthesized and evaluated as potent inhibitors for human immunodeficiency virus type-1 reverse transcriptas
